These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10768956)

  • 1. Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.
    Exner MM; Wu X; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 May; 68(5):2647-54. PubMed ID: 10768956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Oms66 (p66) protein is a Borrelia burgdorferi porin.
    Skare JT; Mirzabekov TA; Shang ES; Blanco DR; Erdjument-Bromage H; Bunikis J; Bergström S; Tempst P; Kagan BL; Miller JN; Lovett MA
    Infect Immun; 1997 Sep; 65(9):3654-61. PubMed ID: 9284133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.
    Shang ES; Champion CI; Wu XY; Skare JT; Blanco DR; Miller JN; Lovett MA
    Infect Immun; 2000 Jul; 68(7):4189-99. PubMed ID: 10858236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.
    Ulbrandt ND; Cassatt DR; Patel NK; Roberts WC; Bachy CM; Fazenbaker CA; Hanson MS
    Infect Immun; 2001 Aug; 69(8):4799-807. PubMed ID: 11447153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
    Cassatt DR; Patel NK; Ulbrandt ND; Hanson MS
    Infect Immun; 1998 Nov; 66(11):5379-87. PubMed ID: 9784547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.
    Gilmore RD; Mbow ML
    Infect Immun; 1999 Oct; 67(10):5463-9. PubMed ID: 10496930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
    Aydintug MK; Gu Y; Philipp MT
    Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
    Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
    Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity.
    Foley DM; Gayek RJ; Skare JT; Wagar EA; Champion CI; Blanco DR; Lovett MA; Miller JN
    J Clin Invest; 1995 Aug; 96(2):965-75. PubMed ID: 7635989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in the presence of complement.
    Sambri V; Armati S; Cevenini R
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):67-71. PubMed ID: 8364524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs.
    Hovius JW; Hovius KE; Oei A; Houwers DJ; van Dam AP
    J Clin Microbiol; 2000 Jul; 38(7):2611-21. PubMed ID: 10878052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice.
    Bockenstedt LK; Hodzic E; Feng S; Bourrel KW; de Silva A; Montgomery RR; Fikrig E; Radolf JD; Barthold SW
    Infect Immun; 1997 Nov; 65(11):4661-7. PubMed ID: 9353047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.
    Fikrig E; Tao H; Kantor FS; Barthold SW; Flavell RA
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4092-6. PubMed ID: 7683420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement-killing of Borrelia burgdorferi. Target antigens and sensitizing antibodies.
    Cacciapuoti B; Ciarrocchi S; Ciceroni L
    Zentralbl Bakteriol; 1998 Jul; 288(1):121-9. PubMed ID: 9728412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer.
    Nelson DR; Rooney S; Miller NJ; Mather TN
    J Parasitol; 2000 Dec; 86(6):1232-8. PubMed ID: 11191897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ; Huebner RC; Kasmiersky V; Barbour AG
    Vaccine; 1997; 15(6-7):739-46. PubMed ID: 9178476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.